We read every piece of feedback, and take your input very seriously. Include my email address so I can be contacted Cancel Submit feedback Saved searches Use saved searches to filter your results more quickly Cancel Create saved search Sign in Sign up Reseting focus {...
Strong Financial PerformanceIBKR reported adjusted EPS slightly ahead of consensus estimates, showcasing the company's ability to exceed market expectations and maintain profitability. Bears Say Financial PerformanceNet Interest Income came in slightly below expectations. ...
30 Day Avg. Volume982,502 Standard Deviation0.20 R-Squared0.14 Alpha0.04 Financial Highlights & Ratios Price to Book (P/B)6.43 Price to Sales (P/S)1.95 Price to Cash Flow (P/CF)26.00 P/FCF Ratio30.30 Enterprise Value/Market CapN/A Enterprise Value/Revenue0.00 Enterprise Value/Gross Profit...
SDLDF Revenue Sorry, this data cannot be displayed at the moment. SDLDF Earnings Per Share Sorry, this data cannot be displayed at the moment.
SSgA SPDR ETFs Europe I Public Limited Company - SPDR MSCI ACWI UCITS ETF is an exchange traded fund launched and managed by State Street Global Advisors Limited. The fund invests in the public equity markets across the globe. It seeks to invest in the stocks of companies operating across div...
AI Monetization ChallengesAI monetization visibility is low and the company tries to frame 2 scenarios for success and failure. Complex Monetization StrategyBaidu talked about going straight to a CPS method for AI monetization, which is more complex and has a higher risk of a long air pocket. ...
CSL (CSL) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.
nJlbGF Detailed Analyst Forecast > 1 Day 3 Days 1 Week 1 Month Similar Stocks Company Price & Change Follow PEGA Pegasystems ― ― PAYC Paycom ― ― PD PagerDuty ― ― SMAR Smartsheet ― ― Compare PRO Stocks > Best Analysts Covering PRO...
Financial PositionSpruce Biosciences ended 2Q24 with $69.7M in cash and cash equivalents, expected to be sufficient to fund operations through the end of 2025 based on the company's current strategic plan. Market OpportunityTildacerfont could be the second CAH drug to market, tapping into a ra...
The Fly Election 2024: Where To Put Your Money Ahead of the Vote 22h ago X GM Market News Analysts Maintain a Cautious Stance After Li Auto Stock’s Recent Surge 5d ago LI The Fly Li Auto call volume above normal and directionally bullish ...